Back to Agenda
Hidden Potential: Turning Today’s Science into Tomorrow’s Cures
Session Chair(s)
Maria Vassileva, PHD
Chief Science and Regulatory Officer
DIA, United States
This opening plenary explores how patient driven science, AI enabled discovery, and regulatory innovation can uncover “hidden cures” in the medicines and data we already have. Through a keynote from David Fajgenbaum and a panel on AI in biopharma, the session asks how we can find, trust, and deliver tomorrow’s cures from today’s science.
Learning Objective : Describe the latent potential of existing medicines and data, and how patient driven science can uncover new uses for known therapies; Explain how AI and advanced analytics can de risk drug discovery and trial design, surfacing overlooked opportunities and improving investment decisions; Identify system level levers: collaboration, regulation, and capital, that can help translate today’s science into tomorrow’s cures more quickly, safely, and equitably.
Speaker(s)
Panelist
David Fajgenbaum
Every Cure, United States
Co-Founder & President of Every Cure
Panelist
Audrey Greenberg, CPA, MBA
Mayo Venture Partner & Chair, United States
Panelist
Rahul Gupta, MD, MBA, MPH
GATC Health, United States
President
Panelist
Tomas J Philipson, PHD
University of Chicago , United States
Daniel Levin Professor of Public Policy Studies
Greg Sarafin
Sovereign AI, United States
Chief Administrative Officer
Have an account?